Can You Take Amlodipine and Simvastatin Together?
FDA guidance on combining amlodipine (calcium channel blocker) and simvastatin (statin). Learn about dose limits and monitoring requireme...
No. Hydrochlorothiazide and lithium should not be combined. Hydrochlorothiazide reduces the kidneys' ability to clear lithium from the body, which greatly increases the risk of lithium toxicity—a serious and potentially life-threatening condition. This combination is classified as contraindicated, meaning the drugs should generally not be used together.
According to the NLM (National Library of Medicine) drug information system, this interaction is rated as contraindicated. The documented description is straightforward: "Hydrochlorothiazide generally should not be given with lithium as it reduces renal clearance and greatly increases risk of lithium toxicity."
The mechanism behind this contraindication is also documented: reduced renal clearance of lithium. In simpler terms, when you take hydrochlorothiazide, your kidneys do not eliminate lithium as efficiently as they normally would. This causes lithium to build up in your body to potentially dangerous levels.
This information comes from the NLM's comprehensive drug labeling system, which integrates FDA-approved prescribing information and other authoritative clinical data. The interaction record was last updated on May 4, 2026.
To grasp why this interaction matters, it helps to understand what each drug does and how they affect the kidneys.
Hydrochlorothiazide (HCTZ) is a thiazide diuretic—a water pill used to treat high blood pressure and fluid retention. It works by increasing the amount of sodium and water your body excretes through urine. This reduces the volume of fluid in your bloodstream and, in turn, lowers blood pressure. However, this same action has an unintended consequence for lithium.
Lithium is a mood-stabilizing medication used to treat bipolar disorder. It works through complex neurochemical mechanisms that remain not fully understood, but its therapeutic effect is narrow and dose-dependent. The difference between an effective dose and a toxic dose is small. This means that even a modest rise in lithium levels can push the drug from therapeutic to toxic.
The interaction occurs at the kidney level. Lithium is filtered by the kidneys and normally excreted into the urine. However, thiazide diuretics like hydrochlorothiazide alter how the kidneys handle sodium, and lithium handling is tied to sodium reabsorption in the kidney tubules. When hydrochlorothiazide causes the kidneys to increase sodium reabsorption, lithium reabsorption increases too. The result: less lithium leaves your body in the urine, and more accumulates in your bloodstream.
This is a documented mechanism, not a theoretical concern. It is well established in clinical practice and appears consistently in prescribing guidance.
Lithium toxicity can cause tremors, confusion, diarrhea, slurred speech, loss of coordination, and in severe cases, seizures, irregular heartbeat, and kidney damage. Because lithium toxicity can develop gradually or suddenly, and because the signs can be subtle, early detection through careful monitoring is critical—which is why the best approach is to avoid this combination entirely whenever possible.
Anyone taking lithium should be aware of this interaction. However, the risk is not uniform across all patients. People at higher risk of harm from a hydrochlorothiazide–lithium combination include those with:
That said, the contraindication applies broadly. It is not only high-risk patients who should avoid this combination; the source record states that hydrochlorothiazide "generally should not be given with lithium." This language reflects the severity and consistency of the interaction.
Scenario 1: A patient with bipolar disorder and high blood pressure. Imagine a patient taking lithium 900 mg daily for mood stability. Six months later, her doctor prescribes hydrochlorothiazide 25 mg daily for hypertension. Neither doctor knows the patient is on the other medication, or they assume the risk can be managed with close monitoring. Over two to three weeks, the patient develops increased tremor, mild confusion, and nausea. A blood test shows her lithium level has risen from 0.8 mEq/L (therapeutic) to 1.5 mEq/L (toxic range). This is a direct result of reduced renal clearance caused by the diuretic. The patient should not have been started on hydrochlorothiazide in the first place; an alternative blood pressure medication should have been selected.
Scenario 2: A patient on both medications seeks medication adjustment. Suppose a patient is already on both drugs due to a prior prescribing error or a gap in communication. If the interaction is discovered, the standard approach would not be to continue both drugs and "monitor closely." Instead, hydrochlorothiazide would be discontinued and replaced with an alternative diuretic or antihypertensive agent that does not interact with lithium (such as a calcium-channel blocker, an ACE inhibitor, or an ARB—angiotensin receptor blocker). Lithium levels would be rechecked after any medication change to ensure they return to the therapeutic range.
If you take lithium and have been prescribed hydrochlorothiazide, or if you think you may be on both, start a conversation with your pharmacist or doctor right away. Here are some key points to raise:
Do not stop taking lithium or hydrochlorothiazide on your own without medical guidance. Stopping lithium abruptly can trigger mood relapse, and stopping blood pressure medication suddenly can raise your risk of cardiovascular events. Instead, work with your healthcare team to coordinate a safe transition plan.
This article is based on drug interaction data sourced from the National Library of Medicine (NLM) and FDA drug labeling. For more information:
Always verify the current labeling of any medication you are taking by checking DailyMed or consulting your pharmacist, as drug information is updated regularly.
If you take hydrochlorothiazide, lithium, or both, use the interaction checker at checkdruginteractions.com to review your complete medication list for potential interactions. This tool will help you identify other drug pairs that may require attention. Then, schedule a conversation with your pharmacist or physician to discuss your medications and ensure they are safe to take together. Your pharmacist is an excellent resource for medication questions and can help coordinate any necessary changes with your doctor.
CDI checks every pair across up to 20 drugs — backed by FDA and NIH data.
Drug interaction data sourced from U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NLM), National Institutes of Health. For informational purposes only. Always consult your pharmacist or physician before making any medication decisions.
FDA guidance on combining amlodipine (calcium channel blocker) and simvastatin (statin). Learn about dose limits and monitoring requireme...
FDA classifies alprazolam and ketoconazole as contraindicated. Learn why this combination is unsafe and what to discuss with your doctor.
Celecoxib and warfarin together carry a major interaction risk. Learn what FDA labeling says, who is at higher risk, and what to discuss ...